Ford reconsidering plans for Tamil Nadu plant amid Trump tariffs

**Ford Reconsidering Plans for Tamil Nadu Plant Amid Trump Tariffs**

*By Akash Pandey | Oct 11, 2025, 02:27 pm*

US auto giant Ford is re-evaluating its plans for the Maraimalai Nagar plant near Chennai, according to The Economic Times. This reconsideration comes in response to the tariffs imposed by former President Donald Trump, which have compelled the company to reassess its financial strategy relating to the facility. A meeting of top executives from Ford’s Michigan headquarters is slated to further discuss the matter.

**Facility Status**

The Maraimalai Nagar plant has been non-operational since mid-2022 after Ford ceased vehicle production in India. Previously, the company had explored repurposing the facility for engine production. However, Trump-era tariff policies have increased costs for American companies exporting to the US, complicating investment plans for the plant.

**Strategic Shift: Focus Moves from India to Europe**

Amid shifting global economic conditions and rising political challenges, Ford is pivoting its focus away from India towards Europe. The company has made substantial investments in its European operations, including a $4.4 billion project in Germany, an electric vehicle initiative in Cologne, a parts manufacturing plant in the UK, and a series of electric vehicle launches supported by extensive battery research.

**Ford’s Continued Commitment to Chennai**

Despite the uncertainties, a Ford spokesperson reiterated the company’s ongoing commitment to its Chennai manufacturing facility. “Our position in relation to our Chennai manufacturing facility has not changed since we confirmed our intention to utilize the plant for manufacturing for export,” the spokesperson stated.

The spokesperson also highlighted that Ford maintains a strong presence in Chennai through its 12,000-strong Ford Business Services team based in the city.

**Government Dialogue**

The Tamil Nadu government continues to engage in regular discussions with Ford representatives concerning the plant’s future. The state government is keen to secure a decision on the plant’s use as part of its broader initiative to bolster Tamil Nadu’s position as a key auto manufacturing hub.

As the situation develops, both Ford and the Tamil Nadu government remain in talks to navigate the challenges and explore viable options for the Maraimalai Nagar facility.
https://www.newsbytesapp.com/news/auto/ford-re-evaluates-tamil-nadu-plant-plans-amid-trump-s-tariffs/story

Kerala Bans All Sresan Pharmaceuticals Medicines From Sale Following Tamil Nadu License Cancellation

Kerala (Thiruvananthapuram): Health Minister Veena George announced that all medicines manufactured by Sresan Pharmaceuticals, a company based in Kanchipuram, Tamil Nadu, have been banned from distribution and sale in Kerala. The move follows action taken by the Tamil Nadu Drugs Controller to cancel the company’s manufacturing license. Meanwhile, the Gujarat Drugs Controller has reported that the Respifresh TR syrup (60ml, Batch No. R01GL2523), manufactured by Rednex Pharmaceuticals Pvt. Ltd., Ahmedabad, failed to meet quality standards. In response, the Kerala Drugs Control Department has immediately halted the distribution and sale of this medicine across the state. The syrup was being distributed by five suppliers in Kerala, who have now been instructed to stop its distribution. Strict action will be taken against anyone found selling the drug. The public has been advised not to use this medicine if they have it in possession. The minister clarified that these medicines are not supplied through government hospitals. She also directed that strict action be taken against establishments that provide this medicine to children below 12 years without a prescription from a registered doctor. Earlier Kerala government constituted a committee to submit a report on the management of pediatric cough syrups following the death of at least 14 children after consumption of Coldrif syrup in Madhya Pradesh’s Chhindwara, Kerala Health Minister Veena George said on Tuesday. Kerala Health Department has also asked the Drugs Controller to issue a notice to pharmacies not to sell pediatric drugs to children without a doctor’s prescription. Veena George said that the State Drugs Controller has imposed a ban on the particular cough syrup, and the Kerala Medical Services Corporation (KMSCL) does not supply the syrup to government hospitals. Kerala Health Minister Veena George’s Statements Speaking to ANI, Veena George said, “It’s unfortunate that 16 children died by consuming this cough syrup Coldrif. The Government of India has issued an advisory on the consumption of cough syrup. In Kerala, the Drugs Controller has issued a notification banning the particular cough syrup Coldrif in all the pharmacies across the state.” “We don’t have this in our essential drugs list. This is not being supplied by the KMSCL, which is our corporation that supplies medicine to government hospitals. But, we are ensuring that the sale is not happening in private hospitals and pharmacies,” the Kerala Minister added. She said that the committee on pediatric cough syrups will submit its report to the Kerala Government. “We have already done this in the case of antibiotics and have strict enforcement in the State. We have established a committee that will submit a report to the government. The committee is particularly focused on the management of pediatric cough, because irrelevant combinations should not be in the syrups. We have decided to issue a guideline regarding the management of pediatric cough, which is very essential,” she said. Furthermore, she alleged that doctors were prescribing cough syrups to children under the age of 2 years, which is not advisable. Veena George said, “We do have a protocol on the consumption of cough syrup. It is not advisable to give cough syrups to children under 2 years old, but this case shows that doctors are prescribing cough syrups to children under 2 years old, which is unscientific and unacceptable. Kerala Health Department has asked the Drugs Controller to issue a notice to pharmacies not to give pediatric drugs to children without a prescription.” (Except for the headline, this article has not been edited by FPJ’s editorial team and is auto-generated from an agency feed.)
https://www.freepressjournal.in/india/kerala-bans-all-sresan-pharmaceuticals-medicines-from-sale-following-tamil-nadu-license-cancellation

Exit mobile version